INTRODUCTION
Galactosyltransferase of human milk is a sialoglycoprotein of Mr approx. 55000 that, on isoelectric focusing, resolves into multiple bands (Gerber et al., 1979) . Although the pl of the bands is in part sialic acid-dependent, the heterogeneity is only slightly decreased by neuraminidase treatment. The structural basis of the isoforms remains to be elucidated. One possibility addressed in the present study is that they represent glycosylation variants of the enzyme glycoprotein. Monoclonal antibodies are available that recognize peripheral and backbone structures of glycoprotein oligosaccharides of N-or O-glycosidic type and they can be applied with ease for deriving structural information on glycoprotein oligosaccharides (Childs et al., 1978; Childs & Feizi, 1981; Childs et al., 1984) . In the present study we have carried out immunoblotting of human milk galactosyltransferase after isoelectric focusing. We detected several bloodgroup-related antigens on the enzyme glycoprotein, but no major differences in their expressions on the different isoforms. Solid-phase radiobinding and inhibition of binding assays using reference blood-group substances and structurally defined oligosaccharides revealed that rabbit antisera to this enzyme contain variable amounts of antibodies directed at the blood-group-related carbohydrate antigens. Immunofluorescence microscopy with human gastrointestinal tissues revealed that these blood-group-related specificities give rise to strong immunofluorescence of epithelial cells.
MATERIALS AND METHODS

Purification of galactosyltransferase and immunization of rabbits
Pooled human milk, or milk from individual donors, was stored until use at -20 'C. Galactosyltransferase was isolated as described previously (Gerber et al., 1979) and stored at -70 'C. Portions were passed over an insolubilized-protein A column to remove trace contaminants of IgG (Wilson et al., 1982) and used to immunize rabbits with five to six subcutaneous injections of 200 ,g of enzyme per injection, of which the first preparation was emulsified in complete Freund's adjuvant. Injections were fortnightly and the immune response was monitored by enzyme-linked immunoadsorbent assay (Berger et al., 1981) .
Antisera
Three rabbit antisera against purified galactosyltransferase were studied. One of these, designated X, was raised against the enzyme from a blood-group-O individual (secretor status unknown); antisera P and Z were against enzyme from milk pools from individuals of unknown blood groups. Affinity-purified antibodies were available from sera X and P and had been isolated by using immunoadsorbents of galactosyltransferase from pooled milk as described by Berger et al. (1981) .
Monoclonal anti-carbohydrate antibodies
The monoclonal antibodies were those used in previous studies (Childs et al., 1983 unless otherwise stated. These consisted of human autoantibodies or mouse hybridoma-derived antibodies to epitopes on accessible backbone structures: IgMWOO (human) anti-Type 1 backbone; anti-i Den, anti-I Ma and anti-I Step (human) anti-Type 2 backbones; M18 (mouse) anti-Type 2 backbones; mouse hybridomaderived antibodies to antigens on fuco-oligosaccharide sequences: CF4 and 11 5C2 anti-(blood-group-Lewisa)-related (Gooi et al., 1983a) , 64/5B93 anti-(blood-group Lewisb) (Messeter et al., 1984) ; Hl 1 anti-(Type 2 blood group H) (Knowles et al., 1982) ; HF33 anti-(Types 1 and 2 blood-group H) (J. Picard &T. Feizi, unpublished work); anti-(SSEA-1) anti-(acl-3-fucosylated Type 2 chain); C14 anti-(2',3-difucosyl Type 2 chain); G49 anti-(blood-group ALeb/Y). The human antibodies were used as sera (1: 300
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Abbreviations used: affi-P and affi-X, affinity-purified antibodies from serum P and serum X respectively; LNDF I, lacto-N-difucohexaose I; LNF II, lacto-N-fucopentaose II; LNF III, lacto-N-fucopentaose III; 3FL, 3-fucosyl-N-acetyl-lactosamine; PBS/BSA, 20 mM-sodium phosphate-buffered saline, pH 7.2, containing 1 mg of bovine serum albumin/ml. § To whom correspondence and reprint requests should be addressed. 605 dilution Ma and Step or 1: 1000 dilution Den and WOO) and the mouse antibodies as 1: 100 dilutions of immune ascites (M18, CF4, 64/5, HI1 and SSEA-1), or as undiluted culture supernatants (HF33 and C14), or as purified IgG (G49 at 18,ug/ml). As negative controls, normal human serum supplemented with a Waldenstrom macroglobulin (4 mg/ml of serum) and monoclonal anti-fibronectin as immune ascites were used at 1:300 and 1:1000 dilution respectively. Glycoproteins and oligosaccharides Referenceblood-groupsubstancesderivedfromovarian cysts were used; their designations and known antigen activities (the latter are shown in parentheses and their full citations were given previously (Gooi et al., 1983a,b; Picard & Feizi, 1983) ; MSS (A, ALeb&Y and H), Beach (B), JS (H and Leb), N-1 (Lea,SSEA-1, I). FT (SSEA-1, I). Two glycoprotein preparations from human meconium were used, one of secretor type (A, H, Lea, Leb, I, i, SSEA-1) and another of non-secretor type (Lea, I, i, SSEAK1) and meconium glycoproteins of secretor type subjected to mild acid hydrolysis (Gooi et al., 1983b) (Roth & Berger, 1982) , immunostaining of the enzyme on nitrocellulose using monoclonal anti-carbohydrate antibodies followed by 1251-labelled anti-mouse or anti-human immunoglobulins, and in some experiments immunostaining after treatment ofthe enzyme on nitrocellulose with neuraminidase from Vibrio cholerae (Behringwerke AG, Marburg, Germany) was performed as described previously (Childs et al., 1983 . The immunostained bands revealed by autoradiography were compared with those detected by immunoperoxidase staining with rabbit anti-galactosyltransferase serum or with Coomassie Blue (Roth & Berger, 1982; Roth et al., 1985) . Solid-phase radiobinding assays Glycoproteins or galactosyltransferase (0.3,g in 100 1ul of PBS) were dried on to plastic wells (Dynatech Laboratories, Billingshurst, West Sussex, U.K.) at 37°C for 18 h. The wells were washed with PBS/BSA and incubated at 4°C for 18 h with 100 ,u of a dilution of the rabbit anti-galactosyltransferase antiserum. After washing with PBS/BSA, 100 #1 ofa 1: 30 dilution of swine anti-rabbit immunoglobulins (Dako Mercia Brocades, Weybridge, Surrey, U.K.) were added and incubation continued at 4°C for 2 h. The wells were washed with PBS/BSA and further incubated at 4°C for 2 h with 2 x 105 c.p.m. of 1251-labelled staphylococcal protein A (Sigma, Poole, U.K.; specific activity 10 ,Ci/,ug. The wells were washed with PBS/BSA, dried, and bound radioactivity was measured in a Nuclear Enterprises 1600 y-radiation counter. In inhibition experiments, the antisera and affinity-purified antibodies were used at dilutions that gave 10-20% of maximal binding to the reference glycoprotein; inhibitor (10 ul) was added to the glycoprotein-coated wells, followed by antibody, and incubated at 4°C for 18 h. The procedure was then as described above. Immunofluorescence A sample of non-neoplastic gastric mucosa was from a patient [Case Ni, blood-group A, secretor ] who had undergone gastrectomy for gastric cancer. A sample of normal small intestine was from a patient (Case Don, blood-group 0, secretor) who had undergone extensive intestinal resection for colon cancer. Immunofluoresence was performed on sections of formalin-fixed, paraffin-embedded, tissues as described by Kapadia et al. (1981) and Thorpe et al. (1983) and on acetone-fixed smears of HeLa cells [suspended from monolayer cultures by treatment with 0.25% (w/v) trypsin (Difco Laboratories, East Molesley, Surrey, U.K.)]. For immunofluorescence, rabbit anti-galactosyltransferase sera were used at 1: 50 dilution; affinity-purified antibodies at 100 #g/ml and fluorescein-conjugated goat antibodies to rabbit IgG (Cappel Laboratories, Downington, PA,, U.S.A., purchased from Dynatech Laboratories) at 1: 240 dilution. As a negative control, normal rabbit serum (1: 50 dilution) was used. For absorption experiments, bloodgroup substance was added to pre-diluted antiserum or eluate (10 ,g of blood-group substance/,I of original serum or 20 ,ug of blood-group substance/,ug of affinity-purified antibody) and the mixtures were incubated at 4°C for 16 h and centrifuged for 5 min in a Beckman Microfuge before use for immunofluorescence.
RESULTS
Blood-group-related carbohydrate antigens are expressed on galactosyltransferase
Immunoblotting of galactosyltransferase ( Fig. 1) GalNAcal-3GalPI-314GlcNAc 11,2 1,4/3 Fucac Fuca recognized by monoclonal antibody G49, was detected in addition to Lea and SSEA-1. All six isoforms of the enzyme separated by isoelectric focusing reacted with these antibodies. The blood-group-A-active enzyme contained two additional bands (designated 2' and 3'), reacting with CF4 antibody and weakly with G49. By contrast, the 2' and 3' bands were absent in the blood-group-O non-secretor enzyme, which showed an additional weak band, 6', revealed by antibody CF4. The expression of Le" on galactosyltransferase was confirmed by a solid-phase radiobinding assay using the second monoclonal antibody, 11 5C2, with Lea-related specificity (results not shown). No immunostaining was observed with the other monoclonal antibodies used and no reactivities were revealed with the anti-I and anti-i antibodies and IgMWOO after neuraminidase treatment of the enzyme glycoprotein. Blood-group-related specificities occur in rabbit antisera to galactosyltransferase
In view of the finding of blood-group-related antigen activities on galactosyltransferase, a search was made for the corresponding specificities in rabbit anti-galactosyltransferase sera. Binding assays with the reference blood-group-A-active ovarian-cyst glycoprotein (MSS) and meconium glycoproteins of non-secetor type showed that the galactosyltransferase antisera contained antibodies reactive with antigenic determinants on one or both glycoproteins, although their titres were lower than those obtained using galactosyltransferase as the immobilized antigen (Fig. 2) . The reactivities of the affinity-purified antibodies, affi-P and affi-X, reflected those of the original antisera (Fig. 2, insets Fig. 3 . Inhibition of binding of antiserum Z, antiserum P and affi-P to the bk)od-group-A-active glycoprotein MSS and of antiserum X and affi-X to meconium glycoproteins of non-secretor type Abbreviations for inhibitors: Mec(s) and Mec(ns), meconium glycoproteins of secretor and non-secretor type respectively; NI, MSS, Beach, JS, F1, reference blood-group substances as described in the Materials and methods section; Mec(s)a, meconium glycoproteins subjected to mild acid hydrolysis in order to remove fucose residues. LNDF I, LNF II, LNF III and 3FL are fucose-containing oligosaccharides described in the Materials and methods section. The concentrations of the glycoprotein inhibitors are given as ,ug/ml and, of the oligosaccharides, nmol in a total reaction volume of 1O #l.
Inhibition-of-binding studies (Fig. 3) showed that the reactivity of serum Z with glycoprotein MSS was predominantly blood-group-A-related; only glycoprotein MSS and the meconium glycoproteins of secretor type with blood-group-A and -H activities were inhibitory, whereas the reactivities with antiserum P and affi-P involved specificities towards structures shared by MSS and the several other glycoproteins, particularly Beach, JS and meconium glycoproteins derived from secretors.
The inhibitory activity of the meconium glycoproteins of secretor type was abolished (with affi-P) or almost completely abolished (with serum P) after mild acid hydrolysis, under conditions which release most of the fucose residues. This is consistent with specificities related to H and Leb antigens or with the Ley antigen structures being predominant in serum P and affi-P.
Inhibition studies with serum X and affi-X (Fig. 3 ) indicated that binding of meconium glycoproteins is mediated by structures that are most strongly expressed on the two meconium glycoproteins and the ovarian-cyst glycoprotein, N-1, all ofwhich are rich in Lea and SSEA-1 antigen structures. This pattern was more clearly seen with affi-X, and here also the antigenic determinant was susceptible to mild acid hydrolysis, indicating the importance of fucose residues for reactivity. The results of the oligosaccharide inhibition assays with affi-X (Fig.  3) confirmed the presence of antibody populations related to Lea and SSEA-1. There was a preferential reaction with the Type 1-based Lea structure, since LNDF I and LNF II were more active inhibitors than the Type 2-based oligosaccharides LNF III and 3FL.
These antibodies with blood-group-related specificities were minor populations among the antibodies to galactosyltransferase, for the binding of the antisera and affinity-purified antibodies to the immobilized enzyme could not be inhibited by the ovarian-cyst and meconium-derived glycoproteins individually or as a mixture at the highest concentrations tested (50 ,ug of glycoprotein/well), whereas galactosyltransferase gave complete inhibition at 3 ,ug/well (results not shown). Panel A shows immunofluorescence of the surface epithelium of the stomach of^a blood-group-A secretor with antigalactosyltransferse serum Z, and panel B shows the lack ofimmunofluorescence after absorption with blood-group-A substance, as described in the Materials and methods section. Panel C shows immunofluorescence of the surface epithelium of small intestine from a blood-group-O secretor with affinity-purified antibodies to galactosyltransferase, affi-P, and panel D shows lack of immunofluorescence after absorption with blood-group-H substance. Panels E and F shows similar immunofluorescence of HeLa cells with antiserum Z before and after absorption with blood-group-A substance. Panels BI, DI, E' and F' are phase-contrast micrographs corresponding to panels B, D, E and F respectively. Magnification x 350 (panels A, B, C and D) and x 560 (panels E and F).
Blood-group-related specificities are involved in surface inimunofluorescence of epithelial cells
The blood-group-related specificities, although minor components, were clearly predominant in the reactivities of the anti-galactosyltransferase sera and affinity-purified antibodies with human gastric and intestinal epithelia derived from individuals of known blood-group and secretor status. Immunohistochemical studies (not described here in detail) have shown that serum Z resembles anti-(blood-group A) serum in reacting with Vol. 238 609 il epithelia from blood-group-A individuals but not with those of blood-group 0; serum P and affi-P resemble anti-(blood-group H) serum in reacting more strongly with epithelia from secretors than those from nonsecretors, and serum X and affi-X resemble anti-(blood group Lea) and anti-(SSEA-1) antibodies in reacting more strongly with epithelia from non-secretors than those from secretors. Absorption of the antisera and the affinity-purified antibodies with appropriate blood-group substances abolished this epithelial immunofluorescence. Illustrated in Fig. 4 , panel A, is immunofluorescence of the gastric surface epithelium of a blood-group-A secretor using antiserum Z, and in Fig. 4, panel B , the abolition of immunofluorescence after absorption with blood-group-A substance (MSS). Fig. 4 , panel C, shows immunofluorescence of small-intestinal epithelium from a blood-group-O secretor with affi-P, and Fig. 4 , panel D, shows the loss of reactivity after absorption with blood-group-H substance (JS). In contrast with the findings with epithelial cells, absorption of the antisera and the affinity-purified antibodies with blood-group substances had no perceptible effect on the Golgi-region immunofluorescence of HeLa cells, as shown for serum Z in Fig. 4 (panel E and F). These results indicate that immunofluorescence ofthe surface epithelial cells, but not that of HeLa cells, is mediated by antibodies with blood-group-related specificities.
DISCUSSION
The conclusions that can be drawn from the present study are, firstly, that the six charge isoforms of human milk galactosyltransferase exhibit blood-group-related carbohydrate determinants to comparable extents. Thus the structural features that determine the differences in isoelectric point of the isoforms are neither related to these epitopes nor to sialic acid, as shown previously (Gerber et al., 1979) . Secondly, the carbohydrate antigens on galactosyltransferase are in part influenced by the blood-group and secretor genes, and antibodies with corresponding specificities occur among rabbit antisera to this enzyme. Thirdly, these blood-group specificities give rise to immunoflurescence of surface epithelial cells.
The finding of blood-group-related carbohydrate specificities in antisera and affinity-purified antibodies to galactosyltransferase has important implications, since these carbohydrate antigens occur on a variety of other glycoproteins. In a previous study (Roth et al., 1985) , immunoblotting with affi-X ofpartially purified intestinal galactosyltransferase and a crude intestinal homogenate after electrophoresis in IO % -(w/v)-polyacrylamide gel, showed in each case an immunoreactivity in the Mr range of galactosyltransferase of human milk. The absence of other major cross-reactive components suggested that the antibodies were monospecific for galactosyltransferase. However, experience with monoclonal antibodies has shown that, even when they react with discrete glycoproteins, the epitopes they recognize may be carbohydrate. Examples are a -monoclonal antibody to an antigenic marker of human fetal endoderm (Gooi et al., 1983c) and several antibodies to the receptor for epidermal growth factor in A43 1 cells (reviewed by Gooi et at., 1985) . These-antibodies, which appeared mnonospecific and reacted with single immunoreactive components in the cells used as immunogens, were directed against blood-group chains. In each case, the glycoprotein in question (a 200 kDa fetal glycoprotein or the 170 kDa receptor for epidermal growth factor) happened to be the main immunoreactive component among the total solubilized glycoproteins of these cells, but in other cell types the antigenic determinants are shared by a variety of glycoproteins and glycolipids . A major class of epithelial glycoproteins, mucins, which express carbohydrate antigens of the blood-group family, do not penetrate 10% polyacrylamide gels and would be overlooked unless electrophoresis with low concentrations of polyacrylamide gel is performed (Feizi, 1983) . In addition they may fail to be electrotransferred on to nitrocellulose and thus fail to immunostain.
Although the carbohydrate antibodies are minor components among the antibodies to galactosyltransferase, they are detectable at the dilutions used for immunohistochemistry of the enzyme glycoprotein. The cell-surface immunoreactivity ofepithelial cells (Pestalozzi et al., 1982; Davis et al., 1984; Roth et al., 1985) and of pre-implantation embryos (Sato et al., 1984) with anti-galactosyltransferase sera or with affinity-enriched antibodies has previously been taken as evidence for the occurrence of this enzyme on cell surfaces. In view-of the occurrence of SSEA-1 on pre-implantation embryos (Gooi et al., 1981) and blood-group A, Lea,. SSEA-1 and related carbohydrate antigens on epithelial surfaces [reviewed by Gooi et al. (1983b) and Feizi et al. (1984) ], it will be important to re-evaluate these previous immunohistochemical observations after absorptions to deplete any carbohydrate specificities in the antigalactosyltransferase reagents and by raising antibodies that react exclusively with the protein moiety of the enzyme glycoprotein.
